Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
DeepSeek R1, the surprisingly efficient and powerful Chinese AI model, has taken the technology industry by storm and is ...
More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand ...
Their mutual friction goes back to the foundational ideals of OpenAI. But now both seem to have Trump’s favour: Elon Musk as ...